Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yestar Healthcare Holdings CoHKSE:02393 +4.55% Median PS Value is HK$0.38 as of Sep. 21, 2026. The stock has 4 warning signs investors should review. Among 343 Medical Devices & Instruments companies, Yestar Healthcare Holdings Co ranks better than 95.34% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Yestar Healthcare Holdings Co's Median PS Value or its related term are showing as below:
HKSE:02393'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.04 Med: 0.1 Max: 0.27
Current: 0.18
During the past 13 years, the highest Price to Median PS Value of Yestar Healthcare Holdings Co was 0.27. The lowest was 0.04. And the median was 0.10.
HKSE:02393's Price-to-Median-PS-Value is ranked better than 95.34% of 343
companies
in the Medical Devices & Instruments industry
Industry Median: 0.7
vs HKSE:02393: 0.18
Yestar Healthcare Holdings Co (HKSE:02393) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Yestar Healthcare Holdings Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.069
/
0.38
=
0.18
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yestar Healthcare Holdings Co Median PS Value Related Terms
Yestar Healthcare Holdings Co Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yestar Healthcare Holdings Co Median PS Value Chart
HKSE:02393 vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, Yestar Healthcare Holdings Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yestar Healthcare Holdings Co Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Yestar Healthcare Holdings Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Yestar Healthcare Holdings Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.5882.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yestar Healthcare Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0.646.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yestar Healthcare Holdings Co (HKSE:02393) has a Median PS Value of HK$0.38 as of Sep. 21, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Yestar Healthcare Holdings Co and its competitors. According to the industry distribution chart, Yestar Healthcare Holdings Co ranks #16 out of 343 companies in the Medical Devices & Instruments industry, placing it in the top 4.7%.
Is Yestar Healthcare Holdings Co's Median PS Value too high?
Yestar Healthcare Holdings Co's current Median PS Value is HK$0.38. Based on the distribution chart, Yestar Healthcare Holdings Co ranks #16 out of 343 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Yestar Healthcare Holdings Co's Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Yestar Healthcare Holdings Co ranks #16 out of 343 companies for Median PS Value. This places Yestar Healthcare Holdings Co in the top 5% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.70, based on 343 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Yestar Healthcare Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yestar Healthcare Holdings Co's current Median PS Value is HK$0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yestar Healthcare Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Yestar Healthcare Holdings Co (HKSE:02393) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.05, compared to a current price of HK$0.07 — trading 38% above its estimated fair value. The current Median PS Value is HK$0.38. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Yestar Healthcare Holdings Co (HKSE:02393), the current Median PS Value is HK$0.38 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yestar Healthcare Holdings Co Ltd is engaged in the manufacture, distribution, and sale of medical imaging products, distribution of In Vitro Diagnostic (IVD) products, and manufacture and sale of dental films. The Group has two reportable operating segments: Imaging printing products segment, which includes the manufacture and sale of colour photographic paper, industrial NDT x-ray films and PWB films, and trading of imaging equipment; and Medical products and equipment segment, which generates maximum revenue and includes manufacture and sale of medical dry films, medical wet films and dental films, and sale of medical equipment and diagnostic reagents. The Group operates its business in Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02393 has been successfully added to your 
